| Literature DB >> 34904195 |
Ioannis Stratos1, Karl-Dieter Heller2, Maximilian Rudert3.
Abstract
PURPOSE: The goal of our study was to conduct an online survey that highlights patterns of practice during total hip arthroplasty (THA).Entities:
Keywords: Approach; Drain; Fast-track-concepts; Minimally invasive surgery; Total hip arthroplasty; Tranexamic acid
Mesh:
Year: 2021 PMID: 34904195 PMCID: PMC8930942 DOI: 10.1007/s00264-021-05188-x
Source DB: PubMed Journal: Int Orthop ISSN: 0341-2695 Impact factor: 3.075
Fig. 1The structure of the survey illustrated as a flowchart. The survey consisted of 17 questions (Q1–Q17). The nodes of the flowchart are marked with rectangles. The sum of responses for each question is given as “Σ,” whereas n demonstrates the number of responses for each answer after a node. (Q1, Do you perform THA? Q2, Which surgical approach do you mainly use? Q3, Do you use a minimally invasive approach as your standard surgical approach? Q4, Which minimally invasive approach do you mainly use? Q5, Who uses MIS for THA in your department? Q6, What implants did you use during the introduction of MIS for THA? Q7, Do you routinely use a drainage? Q8, Do you routinely use tranexamic acid? Q9, How do you apply tranexamic acid? Q10, How many THA are performed annually in your department? Q11, Do you use FT concepts for THA? Q12, What kind of FT THA concepts do you use? Q13, Has the introduction of FT THA led to a reduction of the length of hospital stay? Q14, How long is the average length of hospital stay after THA? Q15, Do you perform “outpatient THA”? Q16, Are you planning to perform “outpatient THA” any soon? Q17: how many years have you been working as a surgeon?)
Survey’s questions and answers. The survey’s questions (Q1–Q17) are marked in bold. Answers are underlined; “Σ” indicates all given data entries for the question. All answers are given as percentage of Σ (%) followed by the absolute values (in parenthesis). Q5: multiple answers were allowed; MIS minimal invasive surgery, THA total hip arthroplasty, FT fast track
| Q1: Do you perform THA? (Σ = 313) | Q9: How do you apply tranexamic acid? (Σ = 244) |
| Systemic, 50.4% (123); systemic and local, 40.6% (99); local, 5.3% (13); systemic and local and oral, 2.1% (5); systemic and oral, 0.8% (2); local and oral, 0.4% (1); oral, 0.4% (1) | |
| Yes, 99% (310); no, 1% (3) | Q10: How many THA are performed annually in your department? (Σ = 308) |
| Q2: Which surgical approach do you mainly use? (Σ = 310) | > 100, 89.0% (274); 50–100, 9.4% (29); 10–50, 1.6% (5) |
| Anterolateral, 51.9% (161); anterior, 19.4% (60); lateral, 13.9% (43); posterior, 9.0% (28); posterolateral, 3.2% (10); SuperPath, 1.9% (6); other, 0.6% (2) | Q11: Do you use FT-concepts for THA? (Σ = 308) |
| Q3: Do you use a minimally invasive approach as your standard surgical approach? (Σ = 310) | No, 54.2% (167); yes, 45.8% (141) |
| Yes, 74.2% (230); no, 25.8% (80) | Q12: What kind of FT THA concepts do you use? (Σ = 139) |
| Q4: Which minimally invasive approach do you mainly use? (Σ = 230) | Own concepts, 81.0% (113); company supported concepts, 19.0% (26) |
| Anterolateral, 54.8% (126); anterior, 28.7% (66); posterior, 8.3% (19); lateral, 3.5% (8); posterolateral, 2.6% (6); SuperPath, 2.2% (5) | Q13: Has the introduction of FT THA led to a reduction of the length of hospital stay? (Σ = 140) |
| Q5: Who uses MIS for THA in your department? (Σ = 230) | Yes: 87.1% (122); no: 12.9% (18) |
| All senior surgeons, 47.8% (110); some senior surgeons, 41.3% (95); all orthopedic registrars, 31.7% (73) | Q14: How long is the average length of hospital stay after THA? (Σ = 308) |
| Q6: What implants did you use during the introduction of MIS for THA? (Σ = 229) | 4–6 days, 51.6% (159); > 6 days, 44.2% (136); 2–4 days, 2.9% (9); 1–2 days, 1.3% (4) |
| Standard implants were used, 63.3% (145); new implants were introduced, 16.6% (38); both applied, 20.1% (46) | Q15: Do you perform “outpatient THA”? (Σ = 307) |
| Q7: Do you routinely use a drainage? (Σ = 305) | No, 99.0% (304); yes, 1.0% (3) |
| No, 64.9% (198); yes, 35.1% (107) | Q16: Are you planning to perform “outpatient THA” any soon? (Σ = 304) |
| Q8: Do you routinely use tranexamic acid? (Σ = 308) | No, 93.8% (285); yes, 6.3% (19) |
| Yes, 79.9% (246); no, 20.1% (62) | Q17: How many years have you been working as a surgeon? (Σ = 306) |
| > 20, 60.1% (184); 10–20, 34.3% (105); 0–10, 5.6% (17) |
Fig. 2Subgroup analysis between MIS (Q3) and a the preferred surgical approach (Q2), b years of surgical practice (Q17), and c length of declared hospital stay (Q14). Data are shown as percent of the sum (Σ). The Σ of each group is given in the second raw of the x-axis; Chi-square test: *p < 0.05. MIS, minimally invasive surgery; for Q2, Q3, Q14, and Q17, see Table 1
Fig. 3Subgroup analysis between a use of TXA (Q8) and use of drain (Q7), b use of FT-concepts (Q11) and MIS (Q3), and c use of FT concepts (Q11) and length of declared hospital stay (Q14). Data are shown as percent of the sum (Σ). The Σ of each group is given in the second raw of the x-axis; Chi-square test: *p < 0.05. MIS, minimally invasive surgery; FT, fast track; TXA, tranexamic acid; for Q3, Q7, Q8, Q11, and Q14, see Table 1